Efficacy of Fludarabine and Mitoxantrone combination regimen in indolent lymphoma and chronic lymphocytic leukemia and the correlation of anti-apoptosis SURVIVIN protein with indolent lymphoma and chronic lymphocytic leukemia. (A prospective study).
AMAL SHAKER ZAKARIA;
Abstract
We conducted our study in oncology department in Kasr El
Aini hospital on 21 patients who presented to our department during
period from August 2004 to April 2009.Patients included in the study
were CLL and low grade lymphoma cases who are going to rec
Aini hospital on 21 patients who presented to our department during
period from August 2004 to April 2009.Patients included in the study
were CLL and low grade lymphoma cases who are going to rec
Other data
| Title | Efficacy of Fludarabine and Mitoxantrone combination regimen in indolent lymphoma and chronic lymphocytic leukemia and the correlation of anti-apoptosis SURVIVIN protein with indolent lymphoma and chronic lymphocytic leukemia. (A prospective study). | Other Titles | دراسة مستقبلية لتقييم آفاءة عقاري الفلوداربين والميتوآسانترون مجتمعين في علاج سرطان الدم الليمفاوي المزمن ومرض اللاهودجكين من الدرجة الأولية وعلاقة المرضين مع مضادات الموت المبرمج (سيرفافين ) بروتين. | Authors | AMAL SHAKER ZAKARIA | Keywords | Efficacy of Fludarabine and Mitoxantrone combination regimen in indolent lymphoma and chronic lymphocytic leukemia and the correlation of anti-apoptosis SURVIVIN protein with indolent lymphoma and chronic lymphocytic leukemia. (A prospective study). | Issue Date | 2009 | Description | We conducted our study in oncology department in Kasr El Aini hospital on 21 patients who presented to our department during period from August 2004 to April 2009.Patients included in the study were CLL and low grade lymphoma cases who are going to rec |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 94632r2478.pdf | 111.39 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.